NAMS
NASDAQ HealthcareNewAmsterdam Pharma Company N.V. - Ordinary Shares
Biotechnology
📊 Market Data
| Price | $29.82 |
|---|---|
| Volume | 512,376 |
| Market Cap | 3.43B |
| Beta | 0.070 |
| RSI (14-Day) | 29.2 Oversold |
| 200-Day MA | $29.57 |
| 50-Day MA | $33.31 |
| 52-Week High | $42.00 |
| 52-Week Low | $14.06 |
| Forward P/E | -22.72 |
| Price / Book | 4.99 |
🎯 Investment Strategy Scores
How NAMS scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
50/100
High dividend yield + low volatility
🚀 Moon Shot
18/100
High growth potential (high beta + oversold)
🔪 Falling Knife
57/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
31/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
52/100
Large-cap, institutional-quality stocks
Find NAMS in your text
Paste any text on the homepage — the tool will extract NAMS and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.